Abstract
Recently, a family tree with a predisposition for the gene of multiple endocrine neoplasia Type 1 has been identified in Tasmania. As the surgical identification and localisation of parathyroid adenomas is facilitated by the administration of methylene blue, an opportunity has presented to measure the plasma concentration of methylene blue and methaemoglobin production.
The study was undertaken to establish whether significant methaemoglobin concentrations were generated during the infusion and whether these concentrations could be related to the corresponding methylene blue concentrations.
Mean peak methylene blue concentrations of 3.72 μgl−1, mean percentage methaemoglobin of 10.0 and a Pa.O2 within acceptable clinical ranges were found. No apparent relationship between methylene blue concentration and methaemoglobin production was found.